Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on August 4, 2026

Aug. 4, 2026

ABBYY 2026 Hackathon Winner Accelerates Mortgage Auditing Review Leveraging Document AI and Large Language Models

Indeterminate GlobeNewswire

Aug. 4, 2026

CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement

Indeterminate GlobeNewswire

Aug. 4, 2026

Lisata Therapeutics Provides Update Following Termination of Merger Agreement

Indeterminate GlobeNewswire

Aug. 4, 2026

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

Indeterminate GlobeNewswire

Aug. 4, 2026

Grey Matters Announces September Opening of its First Brain Dedicated PET Neuroimaging Clinic in the U.S.

Indeterminate GlobeNewswire

Aug. 4, 2026

Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 4, 2026

Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 4, 2026

Certara Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 4, 2026

Dianthus Therapeutics Announces DNTH312, a First-In-Class, Next-Generation Bifunctional Fusion Protein Combining Claseprubart and TACI, for Severe Autoimmune Diseases

Indeterminate GlobeNewswire

Aug. 4, 2026

iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference

Indeterminate GlobeNewswire

Aug. 4, 2026

Nurix Announces $10 Million Milestone Payment Associated with Initiation of a Phase 1 Clinical Trial of a STAT6 Degrader

Indeterminate GlobeNewswire

Aug. 4, 2026

Bioxytran Leverages Artificial Super Intelligence (ASI) to Design Broad-Spectrum Antiviral and Anti-Cancer Metastasis Drugs

Indeterminate GlobeNewswire

Aug. 4, 2026

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

Indeterminate GlobeNewswire

Aug. 4, 2026

Vantage Biosciences Completes Enrollment in Phase 2 SeeClear Study of Oral Oruvestat in Non-Proliferative Diabetic Retinopathy

Indeterminate GlobeNewswire

Aug. 4, 2026

Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity

Indeterminate GlobeNewswire

Aug. 4, 2026

BioNTech veröffentlicht Ergebnisse für das zweite Quartal 2026 sowie Informationen zur Geschäftsentwicklung

Indeterminate GlobeNewswire

Aug. 4, 2026

BioNTech Announces Second Quarter 2026 Financial Results and Corporate Update

Indeterminate GlobeNewswire

Aug. 4, 2026

Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference

Indeterminate GlobeNewswire

Aug. 4, 2026

MADONNA: CLUB CONFESSIONS AMSTERDAM WITH MISTR

Indeterminate GlobeNewswire

Aug. 4, 2026

CervoMed Announces Neflamapimod Awarded Innovation Passport Designation Under the UK Innovative Licensing and Access Pathway (ILAP) for Treatment of Dementia with Lewy Bodies (DLB)

Indeterminate GlobeNewswire